J&J Gouged $2M For HIV Meds, Health Care Nonprofit Says

Law360, Los Angeles (October 31, 2013, 10:03 PM EDT) -- Johnson & Johnson inflated costs for HIV/AIDS medications it sold to nonprofits entitled to federally mandated discount rates, costing AIDS Healthcare Foundation $2 million over eight years, according to a suit launched in California state court Wednesday that included claims of unfair competition and contract breach.

California-based AHF claims the federal Public Health Services Act grants it discounts on HIV/AIDS medications, including Prezista and Intelence, made by J&J and its subsidiaries, but says it was charged full price for the drugs through a third-party distributor. AHF...
To view the full article, register now.